Affordable Access

deepdyve-link
Publisher Website

Studying the enhancement of programmed cell death by combined AG1024 and paclitaxel in a model of chronic myelogenous leukemia.

Authors
  • Cheng, Hao-Yuan1
  • Ko, Fu-Hsiang2
  • 1 Department of Materials Science and Engineering, National Chiao Tung University, Taiwan, ROC. Electronic address: [email protected] , (Taiwan)
  • 2 Department of Materials Science and Engineering, National Chiao Tung University, Taiwan, ROC. Electronic address: [email protected] , (Taiwan)
Type
Published Article
Journal
Life sciences
Publication Date
May 02, 2014
Volume
102
Issue
2
Pages
118–126
Identifiers
DOI: 10.1016/j.lfs.2014.03.014
PMID: 24657894
Source
Medline
Keywords
License
Unknown

Abstract

In summary, the present study shows that the combination of AG1024 with paclitaxel inhibited model cancer cell proliferation, suggesting a new use of paclitaxel-based chemotherapy for cancer control.

Report this publication

Statistics

Seen <100 times